ASENTRA

This brand name is authorized in Croatia, Estonia, Lithuania, Poland, Romania.

Active ingredients

The drug ASENTRA contains one active pharmaceutical ingredient (API):

1	Sertraline UNII UTI8907Y6X - SERTRALINE HYDROCHLORIDE
	Sertraline is a potent and specific inhibitor of neuronal serotonin (5-HT) uptake in vitro, which results in the potentiation of the effects of 5-HT in animals. It has only very weak effects on norepinephrine and dopamine neuronal reuptake.
	Read more about Sertraline

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB06	Sertraline	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1013746, 1143100
HR	Agencija za lijekove i medicinske proizvode	HR-H-681228481, HR-H-809836918
LT	Valstybinė vaistų kontrolės tarnyba	1003515, 1003516, 1088640
PL	Rejestru Produktów Leczniczych	100110576, 100110613, 100240758, 100468854
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W12873001, W12874001